Kymera Therapeutics, Inc. has grown revenue 27% a year over three years and 10% a year over five. Revenue growth, 3-year annual rate: +27% (Biotechnology median +21%). Revenue growth, 5-year rate: +10%, growth has picked up over the last three years. Years of annual history on file: 7, FY2019 to FY2025, as filed.

KYMRKymera Therapeutics, Inc.

HealthcareUSD

$125.37

$37.6852 weeks$127.24

Is it growing?

Is KYMR growing?

Kymera Therapeutics, Inc. has grown revenue 27% a year over three years and 10% a year over five.

+27%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +10%
Revenue growth, 5-year rate · +27% over three · growth has picked up over the last three years
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›